Literature DB >> 9694731

On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G.

D Garwicz1, A Lindmark, A M Persson, U Gullberg.   

Abstract

The serine protease cathepsin G is synthesized during the promyelomonocytic stage of neutrophil and monocyte differentiation. After processing, including removal of an amino-terminal propeptide from the catalytically inactive proform, the active protease acquires a mature conformation and is stored in azurophil granules. To investigate the importance of the proform-conformation for targeting to granules, a cDNA encoding a double-mutant form of human preprocathepsin G lacking functional catalytic site and amino-terminal prodipeptide (CatG/Gly201/triangle upGly19Glu20) was constructed, because we were not able to stably express a mutant lacking only the propeptide. Transfection of the cDNA to the rat basophilic leukemia RBL-1 and the murine myeloblast-like 32D cl3 cell lines resulted in stable, protein-expressing clones. In contrast to wild-type proenzyme, CatG/Gly201/triangle upGly19Glu20 adopted a mature conformation cotranslationally, as judged by the early acquisition of affinity to the serine protease inhibitor aprotinin, appearing before the carboxyl-terminal processing and also in the presence of the Golgi-disrupting agent brefeldin A. The presence of a mature amino-terminus was confirmed by amino-terminal radiosequencing. As with wild-type proenzyme, CatG/Gly201/triangle upGly19Glu20 was proteolytically processed carboxyl-terminally and glycosylated with asparagine-linked carbohydrates that were converted into complex forms. Furthermore, it was targeted to granules, as determined by subcellular fractionation. Our results show that the initial proform-conformation is not critical for intracellular sorting of human cathepsin G. Moreover, we demonstrate that double-mutant cathepsin G can achieve a mature conformation before carboxyl-terminal processing of the proform. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694731

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.

Authors:  Shelley M Lawrence; Ross Corriden; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2018-02-07       Impact factor: 11.056

3.  A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

Authors:  Mao Zhang; Pariya Sukhumalchandra; Atim A Enyenihi; Lisa S St John; Sally A Hunsucker; Elizabeth A Mittendorf; Anna Sergeeva; Kathryn Ruisaard; Zein Al-Atrache; Patricia A Ropp; Haroon Jakher; Tania Rodriguez-Cruz; Gregory Lizee; Karen Clise-Dwyer; Sijie Lu; Jeffrey J Molldrem; Gary L Glish; Paul M Armistead; Gheath Alatrash
Journal:  Clin Cancer Res       Date:  2012-11-12       Impact factor: 12.531

4.  Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.

Authors:  April M Adkison; Sofia Z Raptis; Diane G Kelley; Christine T N Pham
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  The human brm protein is cleaved during apoptosis: the role of cathepsin G.

Authors:  J R Biggs; J Yang; U Gullberg; C Muchardt; M Yaniv; A S Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

6.  Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.

Authors:  Ole E Sørensen; Stine N Clemmensen; Sara L Dahl; Ole Østergaard; Niels H Heegaard; Andreas Glenthøj; Finn Cilius Nielsen; Niels Borregaard
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

7.  Complementary LC-MS/MS-Based N-Glycan, N-Glycopeptide, and Intact N-Glycoprotein Profiling Reveals Unconventional Asn71-Glycosylation of Human Neutrophil Cathepsin G.

Authors:  Ian Loke; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Biomolecules       Date:  2015-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.